News & media

  • COMPANY ANNOUNCEMENT

    Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026

  • PRESS RELEASE

    Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma as of March 31, 2026

  • COMPANY ANNOUNCEMENT

    Resolutions from Zealand Pharma's Annual General Meeting 2026

  • PRESS RELEASE

    Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

  • COMPANY ANNOUNCEMENT

    Zealand Pharma increases its share capital as a result of the exercise of employee warrants

  • PRESS RELEASE

    Zealand Pharma to participate in upcoming investor conferences in March 2026

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity

  • COMPANY ANNOUNCEMENT

    Zealand Pharma convenes its Annual General Meeting 2026

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Financial Results for the Full Year 2025

  • PRESS RELEASE

    Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830

  • PRESS RELEASE

    Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts